Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Top Downloads
    • Annual Meeting Abstracts
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • Rights and Permissions
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Top Downloads
    • Annual Meeting Abstracts
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • Rights and Permissions
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania E. Tsitsilonis, Angelos D. Gritzapis, Roula Sotiriadou and Michael Papamichail
J Immunol April 1, 2000, 164 (7) 3902-3912; DOI: https://doi.org/10.4049/jimmunol.164.7.3902
Constantin N. Baxevanis
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis F. Voutsas
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ourania E. Tsitsilonis
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelos D. Gritzapis
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roula Sotiriadou
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Papamichail
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 164 no. 7 3902-3912
DOI 
https://doi.org/10.4049/jimmunol.164.7.3902
PubMed 
10725753

Published By 
The American Association of Immunologists, Inc.
Print ISSN 
0022-1767
Online ISSN 
1550-6606
History 
  • Received July 26, 1999
  • Accepted January 10, 2000
  • Published online April 1, 2000.

Copyright & Usage 
Copyright © 2000 by The American Association of Immunologists

Author Information

  1. Constantin N. Baxevanis1,
  2. Ioannis F. Voutsas,
  3. Ourania E. Tsitsilonis,
  4. Angelos D. Gritzapis,
  5. Roula Sotiriadou and
  6. Michael Papamichail
  1. Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
View Full Text

Article usage

Article usage: September 2000 to January 2019

AbstractFullPdf
Sep 2000011
Oct 200093722
Nov 2000183018
Dec 2000112424
Total 2000389265
Jan 200144720
Feb 200132529
Mar 200152419
Apr 200131934
May 200152932
Jun 200111718
Jul 200121418
Aug 200141917
Sep 200141312
Oct 200133516
Nov 200141819
Dec 200151213
Total 200143272247
Jan 200253324
Feb 200211915
Mar 200201623
Apr 200232026
May 200251316
Jun 200231622
Jul 200201112
Aug 20021613
Sep 200211410
Oct 200231014
Nov 200221320
Dec 2002395
Total 200227180200
Jan 200321016
Feb 20034511
Mar 20034811
Apr 200301412
May 200351510
Jun 20033115
Jul 200315109
Aug 2003111411
Sep 20036126
Oct 200311112
Nov 2003142215
Dec 200391810
Total 200384150118
Jan 200462412
Feb 200491110
Mar 200411186
Apr 2004122319
May 200492719
Jun 2004122010
Jul 200412162
Aug 200411256
Sep 20047227
Oct 20046197
Nov 20048239
Dec 20048142
Total 2004111242109
Jan 200563313
Feb 20058319
Mar 2005113215
Apr 200562014
May 20052206
Jun 20053196
Jul 20057199
Aug 200541117
Sep 20056135
Oct 200571412
Nov 200571712
Dec 200571611
Total 200574245129
Jan 200692213
Feb 20065185
Mar 2006263
Apr 2006195
May 20064176
Jun 2006296
Jul 20062126
Aug 20064103
Sep 20065139
Oct 20065126
Nov 20065145
Dec 20061177
Total 20064515974
Jan 200751012
Feb 20074187
Mar 20076138
Apr 20079811
May 20077153
Jun 2007578
Jul 200711458
Aug 2007776
Sep 2007684
Oct 20074107
Nov 20077913
Dec 20071165
Total 20078215692
Jan 2008947
Feb 20081522
Mar 2008621015
Apr 20082267
May 200839912
Jun 200815166
Jul 20083575
Aug 200842207
Sep 200859257
Oct 20083577
Nov 2008988
Dec 2008466
Total 200834612089
Jan 2009992
Feb 20096117
Mar 200911126
Apr 20091465
May 2009352
Jun 2009678
Jul 20097142
Aug 2009251
Sep 20092533
Oct 20095921
Nov 20094186
Dec 20094113
Total 20091879346
Jan 2010457
Feb 2010297
Mar 20106108
Apr 2010471
May 2010775
Jun 2010364
Jul 20103107
Aug 2010593
Sep 2010745
Oct 2010533
Nov 2010767
Dec 20106912
Total 2010598569
Jan 2011876
Feb 2011344
Mar 2011721
Apr 2011378
May 2011534
Jun 2011832
Jul 2011546
Aug 2011621
Sep 2011434
Oct 20111243
Nov 2011121010
Dec 2011834
Total 2011815253
Jan 2012473
Feb 2012586
Mar 2012364
Apr 2012532
May 2012944
Jun 2012940
Jul 20128143
Aug 20121184
Sep 2012843
Oct 2012549
Nov 2012879
Dec 2012445
Total 2012797352
Jan 20131078
Feb 20135229
Mar 20137117
Apr 20139165
May 201310169
Jun 2013365
Jul 2013341
Aug 2013293
Sep 2013222
Oct 201341010
Nov 2013634
Dec 20131656
Total 20137711169
Jan 20141343
Feb 2014602
Mar 2014944
Apr 2014814
May 2014377
Jun 20141031
Jul 201415159
Aug 2014722
Sep 2014868
Oct 2014696
Nov 2014392
Dec 2014242
Total 2014906450
Jan 2015246
Feb 2015542
Mar 2015953
Apr 2015531
May 2015052
Jun 2015088
Jul 2015745
Aug 2015342
Sep 20151656
Oct 2015893
Nov 2015537
Dec 2015443
Total 2015645848
Jan 2016929
Feb 2016567
Mar 20167517
Apr 20169208
May 20169810
Jun 2016631
Jul 201621010
Aug 2016569
Sep 2016612
Oct 20161323
Nov 20161077
Dec 2016342
Total 2016847485
Jan 2017272
Feb 2017262
Mar 2017151
Apr 2017496
May 2017263
Jun 2017196
Jul 20171106
Aug 2017195
Sep 2017062
Oct 2017178
Nov 2017175
Dec 2017263
Total 2017188749
Jan 20182145
Feb 2018655
Mar 2018053
Apr 2018083
May 20182108
Jun 201821310
Jul 20180106
Aug 20180101
Sep 20180711
Oct 2018186
Nov 201811213
Dec 20181165
Total 20181511876
Jan 20190117
Total 20190117
Total160424421727

PreviousNext
Back to top

In this issue

The Journal of Immunology: 164 (7)
The Journal of Immunology
Vol. 164, Issue 7
1 Apr 2000
  • Table of Contents
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
Citation Tools
Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor
Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania E. Tsitsilonis, Angelos D. Gritzapis, Roula Sotiriadou, Michael Papamichail
The Journal of Immunology April 1, 2000, 164 (7) 3902-3912; DOI: 10.4049/jimmunol.164.7.3902

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor
Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania E. Tsitsilonis, Angelos D. Gritzapis, Roula Sotiriadou, Michael Papamichail
The Journal of Immunology April 1, 2000, 164 (7) 3902-3912; DOI: 10.4049/jimmunol.164.7.3902
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Differential Susceptibility to Staphylococcal Superantigen (SsAg)-Induced Apoptosis of CD4+ T Cells from Atopic Dermatitis Patients and Healthy Subjects: The Inhibitory Effect of IL-4 on SsAg-Induced Apoptosis
  • HIV-1 Vaccination Administered Intramuscularly Can Induce Both Systemic and Mucosal T Cell Immunity in HIV-1-Uninfected Individuals
  • Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Show more CLINICAL IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2019 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606